GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Shine-On BioMedical Co 6926.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

58.90

+6.13%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 30.0m

FY2021FY2025

Net income

−TWD 110.3m

FY2021FY2025

Free cash flow

−TWD 115.8m

FY2021FY2025

Shareholders' equity

TWD 907.3m

FY2021FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021
RevenueTWD 30.0m—TWD 9.5m——
Gross profitTWD 30.0m−TWD 2.2mTWD 6.7m−TWD 1.6m−TWD 638,000
Research and developmentTWD 137.8mTWD 119.3mTWD 54.2mTWD 6.9mTWD 6.0m
Operating income−TWD 125.5m−TWD 136.1m−TWD 62.7m−TWD 21.8m−TWD 8.6m
Net income−TWD 110.3m−TWD 118.9m−TWD 37.2m−TWD 19.5m−TWD 8.4m
Diluted earnings per share-2.21-2.39-0.75-0.41-0.19

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021
Total assetsTWD 950.9mTWD 1.06bnTWD 1.16bnTWD 1.18bnTWD 911.8m
Cash and short-term investments—TWD 1.04bnTWD 1.14bnTWD 1.17bnTWD 906.0m
Total liabilitiesTWD 43.7mTWD 42.2mTWD 23.3mTWD 4.1mTWD 4.3m
Debt—TWD 2.6mTWD 538,000TWD 1.5mTWD 2.7m
Shareholders' equityTWD 907.3mTWD 1.02bnTWD 1.14bnTWD 1.17bnTWD 907.6m
Shares outstanding50m50m50m48m45m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021
Cash from operations−TWD 114.7m−TWD 91.4m−TWD 26.9m−TWD 21.7m−TWD 6.3m
Capital spending−TWD 1.0m−TWD 608,000−TWD 662,000−TWD 2.8m−TWD 3.0m
Free cash flow−TWD 115.8m−TWD 92.1m−TWD 27.5m−TWD 24.4m−TWD 9.3m

Latest quarters

By quarter end

Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Dec 2022Jun 2022Dec 2021
Revenue———TWD 9.5m————
Gross profit−TWD 1.0m−TWD 1.1m−TWD 2.2mTWD 6.7m————
Operating income−TWD 51.6m−TWD 81.8m−TWD 54.3m−TWD 36.1m−TWD 26.6m−TWD 11.7m−TWD 10.0m−TWD 4.2m
Net income−TWD 44.6m−TWD 72.4m−TWD 46.5m−TWD 24.4m−TWD 12.8m−TWD 14.4m−TWD 5.1m−TWD 4.2m
Diluted earnings per share-0.90-1.45-0.93-0.49-0.26-0.30-0.11-0.09
Cash from operations−TWD 83.0m−TWD 47.0m−TWD 44.0m−TWD 16.0m−TWD 10.0m−TWD 15.0m−TWD 5.0m−TWD 3.0m
Capital spending———————−TWD 1.0m
Free cash flow———————−TWD 4.0m
Total assetsTWD 982.1mTWD 1.06bnTWD 1.11bnTWD 1.16bnTWD 1.16bnTWD 1.18bn—TWD 911.8m
Cash and short-term investmentsTWD 956.6mTWD 1.04bnTWD 1.09bnTWD 1.14bnTWD 1.16bnTWD 1.17bn—TWD 906.0m
DebtTWD 2.6mTWD 2.5mTWD 1.4mTWD 1.1mTWD 984,000TWD 538,000—TWD 1.2m
Shareholders' equityTWD 972.9mTWD 1.02bnTWD 1.09bnTWD 1.14bnTWD 1.16bnTWD 1.17bn—TWD 907.6m

Financial ratios

Data as of 23 Oct 2026

FY2025FY2024FY2023FY2022FY2021
Gross margin100.0%—70.0%——
Operating margin-368.0%—-366.7%——
Net margin-367.6%—-390.2%——
Return on equity-12.2%-11.7%-3.3%-1.7%-0.9%
Return on assets-11.6%-11.2%-3.2%-1.7%-0.9%
Free cash flow yield-3.5%-2.8%-0.8%-0.6%-0.1%
Earnings growth-7.2%219.9%90.2%131.8%—
Current ratio21.48x25.92x49.61x369.30x330.89x
Debt to equity—0.00x0.00x0.00x0.00x
Equity ratio95.4%96.0%98.0%99.6%99.5%
Interest coverage-4088.59x-4560.23x-2686.38x-838.12x-525.94x
R&D as a share of sales459.5%—569.5%——
Buybacks as a share of market value0.0%0.0%-4.1%-5.3%—

Growth per year

Compound annual rate

3 years5 years10 years
Operating income79.2%——
Net income78.0%——

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022
Price to earnings-31.6-28.6-85.6-153.2
Price to sales116.2—334.1—

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.